{
  "id": "f480e7ee-fa1e-4d46-8703-fb3a296c8ba0",
  "title": "Teva Pharmaceutical shares surged for seven straight sessions",
  "link": "https://seekingalpha.com/news/4390767-teva-pharmaceutical-shares-surged-for-seven-straight-sessions?utm_source=feed_news_all\u0026utm_medium=referral\u0026feed_item_type=news",
  "description": "",
  "author": "",
  "published": "Tue, 24 Dec 2024 16:21:36 -0500",
  "source": "https://seekingalpha.com/market_currents.xml",
  "categories": [
    "teva"
  ],
  "byline": "Khushi Singh",
  "length": 325,
  "excerpt": "Read about Teva Pharmaceutical's recent stock performance, analyst ratings, and positive trial results for their experimental antibody therapy.",
  "siteName": "Seeking Alpha",
  "favicon": "https://seekingalpha.com/samw/static/images/favicon-192x192.png",
  "text": "HealthcareOn the Move Teva Pharmaceutical (NYSE:TEVA) shares rose for seven straight sessions, as the stock closed about 1% higher at $22.42 on Tuesday. The Israeli drugmaker stock added 34.5% in the preceding six sessions. The stock has more than doubled so far this year, climbing nearly 115%, dwarfing Recommended For You",
  "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
  "html": "\u003cdiv id=\"readability-page-1\" class=\"page\"\u003e\u003cdiv data-test-id=\"grid-col-main\"\u003e\u003cdiv data-test-id=\"card-container\"\u003e\u003cheader\u003e\u003cdiv data-test-id=\"quick-links\"\u003e\u003cul\u003e\u003cli\u003e\u003ca data-test-id=\"theme-links-item\" href=\"https://seekingalpha.com/market-news/healthcare#source=section%3Amain_content%7Csection_asset%3Athemes%7Cbutton%3Ahealthcare%7Cfirst_level_url%3Anews\"\u003e\u003cspan\u003e\u003cspan\u003eHealthcare\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/li\u003e\u003cli\u003e\u003ca data-test-id=\"theme-links-item\" href=\"https://seekingalpha.com/market-news/on-the-move#source=section%3Amain_content%7Csection_asset%3Athemes%7Cbutton%3Aon-the-move%7Cfirst_level_url%3Anews\"\u003e\u003cspan\u003e\u003cspan\u003eOn the Move\u003c/span\u003e\u003c/span\u003e\u003c/a\u003e\u003c/li\u003e\u003c/ul\u003e\u003c/div\u003e\u003c/header\u003e\u003cdiv data-test-id=\"content-container\"\u003e \u003cp\u003eTeva Pharmaceutical (\u003cspan\u003eNYSE:\u003ca href=\"https://seekingalpha.com/symbol/TEVA\" title=\"Teva Pharmaceutical Industries Limited\"\u003eTEVA\u003c/a\u003e\u003c/span\u003e) shares rose for seven straight sessions, as the stock closed about 1% higher at $22.42 on Tuesday.\u003c/p\u003e \n\u003cp\u003eThe Israeli drugmaker stock added 34.5% in the preceding six sessions. The stock has more than doubled so far this year, climbing nearly 115%, dwarfing\u003c/p\u003e \u003c/div\u003e\u003c/div\u003e\u003cdiv data-test-id=\"recommended-section\"\u003e\u003cp\u003e\u003ch4 data-test-id=\"recommended-for-you-card-title\"\u003eRecommended For You\u003c/h4\u003e\u003c/p\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e",
  "readingTime": "Less than 1 min",
  "publishedTime": "2024-12-24T21:21:36Z",
  "modifiedTime": "2024-12-24T16:22:00-05:00"
}
